Inspire Medical Systems INSP Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85.8%+1.1pp | 85.4%+0.7pp | 84.9%+0.1pp | 84.5%-0.4pp | 84.7%0.0pp | |
| Operating margin | 5.6%— | 5.6%— | 4.2%— | —— | —— | |
| Net margin | 14.3%— | 15.9%— | 5%— | —— | —— | |
| Returns | ||||||
| Return on equity | 18.4%— | 19.8%— | 6.5%— | —— | —— | |
| Return on invested capital | 7.7%— | 8%— | 5.4%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.1×-0.1× | 1.1×0.0× | 1.1×0.0× | 1.1×+0.1× | 1.2×+0.1× | |
| Liquidity | ||||||
| Current ratio | 6.3×-2.7× | 6.1×-1.1× | 5.3×-2.6× | 6.1×-3.1× | 9×+1.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -1×— | -1.1×— | -1.6×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $27.61+31.6% | $26.25+16.3% | $22.52-1.0% | $22.97+9.5% | $20.97+5.5% | |
| Valuation | ||||||
| Market capitalization | $1.24B-67.8% | $2.68B-51.8% | $2.19B-65.0% | $3.91B-1.4% | $4.74B-25.5% | |
| Price / earnings | 9.5×-48.6× | 18.4×— | 49.3×— | —— | —— | |
| Price / sales | 1.4×-3.2× | 2.9×-4.0× | 2.5×-5.8× | 4.5×-1.1× | 5.6×-4.0× | |
| Price / book | 1.6×-4.5× | 3.4×-4.6× | 3.3×-5.7× | 5.8×-0.4× | 7.5×-3.3× | |
| EV / EBITDA | 17.5×-48.1× | 40.2×— | 42.8×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Inspire Medical Systems's profit margins?
- Inspire Medical Systems (INSP) runs a 85.8% gross margin and a 5.6% operating margin, with a 14.3% net margin.
- Where do Inspire Medical Systems's ratios come from?
- Every ratio is computed from Inspire Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
